TAYSHA GENE THERAPIES INC (TSHA) Institutional Ownership and Insiders Activity

TAYSHA GENE THERAPIES INC (TSHA) is widely held by institutional investors, with 2 tracked firms reporting positions valued at approximately $5.18M based on SEC Form 13F filings for the quarter ended March 31, 2026.

Renaissance Technologies LLC is the largest disclosed holder, reporting approximately $1.85M in TSHA holdings in its latest filing.

Recent insider activity includes 5 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.